Chemical and Biological Evaluations of an <sup>111</sup> In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model
- DOI
- 10.1089/cbr.2008.0528
- Published
- 2008-12
- Container
- Cancer Biotherapy and Radiopharmaceuticals
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1089/cbr.2008.0528,
title = {Chemical and Biological Evaluations of an
<sup>111</sup>
In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model},
author = {Mitra Ahmadi and Lucie Sancey and Arnaud Briat and Laurent Riou and Didier Boturyn and Pascal Dumy and Daniel Fagret and Catherine Ghezzi and Jean-Philippe Vuillez},
year = {2008},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
doi = {10.1089/cbr.2008.0528},
url = {https://doi.org/10.1089/cbr.2008.0528}
}RIS
TY - JOUR
TI - Chemical and Biological Evaluations of an
<sup>111</sup>
In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model
AU - Mitra Ahmadi
AU - Lucie Sancey
AU - Arnaud Briat
AU - Laurent Riou
AU - Didier Boturyn
AU - Pascal Dumy
AU - Daniel Fagret
AU - Catherine Ghezzi
AU - Jean-Philippe Vuillez
PY - 2008
JO - Cancer Biotherapy and Radiopharmaceuticals
DO - 10.1089/cbr.2008.0528
UR - https://doi.org/10.1089/cbr.2008.0528
ER - APA
Ahmadi, M., Sancey, L., Briat, A., Riou, L., Boturyn, D., Dumy, P., Fagret, D., Ghezzi, C., & Vuillez, J. (2008). Chemical and Biological Evaluations of an <sup>111</sup> In-Labeled RGD-Peptide Targeting Integrin Alpha(V) Beta(3) in a Preclinical Tumor Model. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2008.0528
Source records
- crossref · retrieved 2026-09-26T16:09:43.235Z